ArticleBioengineered2021

CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis.

Wei Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.